Hi.

Welcome to my blog. I document my adventures in travel, style, and food. Hope you have a nice stay!

 Topical endocannabinoid for atopic dermatitis

Topical endocannabinoid for atopic dermatitis

Study suggests that a newly developed topical endocannabinoid membrane transporter inhibitor can  minimized allergic flares and pruritus in dogs with atopic dermatitis. 

A study aimed to test the effects of a 1% solution of a topical endocannabinoid membrane transporter inhibitor on pruritus and dermatitis in atopic dermatitis. Nineteen Beagles that had confirmed allergy to dust mites were given treatment twice a day and evaluated twice weekly for 28 days. Significant decrease on pruritus with treatment and no adverse effects were noted. 

 

Read more by clicking on the link below:

Double blinded, vehicle controlled, crossover study on the efficacy of a topical endocannabinoid membrane transporter inhibitor in atopic Beagles.

Differences in clinicopathologic variables in Borrelia seroactive and seronegative dogs

Differences in clinicopathologic variables in Borrelia seroactive and seronegative dogs

Blue tongue disease reported in Kentucky deer

Blue tongue disease reported in Kentucky deer